Sanofi (SNY) Long-Term Investments (2009 - 2026)

Sanofi has reported Long-Term Investments for 18 years, with the latest figure at $3.7 billion in Q2 2026.

• Quarterly Long-Term Investments fell 8.06% year-over-year to $3.7 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.7 billion (down 8.06% YoY) and the FY2025 annual result came in at $3.8 billion, up 1023.45% from the prior year.
• Long-Term Investments fell to $3.7 billion in Q2 2026 per SNY's latest filing, from $3.8 billion in the prior quarter.
• Over five years, Long-Term Investments peaked at $4.6 billion in Q2 2023 and troughed at $337.7 million in Q4 2024.
• A 5-year average of $2.7 billion and a median of $3.7 billion in 2026 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2024 and 2025: Long-Term Investments slumped 42.55% in 2024, then surged 1023.45% in 2025.
• Over 5 years, Long-Term Investments stood at $690.7 million in 2022, then tumbled by 33.95% to $456.2 million in 2023, then slipped by 25.98% to $337.7 million in 2024, then soared by 1023.45% to $3.8 billion in 2025, then fell by 1.74% to $3.7 billion in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $3.7 billion, $3.8 billion, and $4.1 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.